Pier Luigi Meroni

Research interests

Publications

• The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria

  Arthritis & Rheumatology · 2023 · https://doi.org/10.1002/art.42624

• 2023 ACR/EULAR antiphospholipid syndrome classification criteria

  Annals of the Rheumatic Diseases · 2023 · 10.1136/ard-2023-224609

• Complement activation in patients with COVID-19: A novel therapeutic target

  Journal of Allergy and Clinical Immunology · 2020 · https://doi.org/10.1016/j.jaci.2020.05.006

• 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

  Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2018-214819

• 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

  Arthritis & Rheumatology · 2019 · https://doi.org/10.1002/art.40930

• EULAR recommendations for the management of antiphospholipid syndrome in adults

  Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2019-215213

• EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209770

• 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends

  Autoimmunity Reviews · 2014 · 10.1016/j.autrev.2014.05.001

• Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

  Annals of the Rheumatic Diseases · 2014 · 10.1136/annrheumdis-2013-204838

• International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

  Annals of the Rheumatic Diseases · 2013 · 10.1136/annrheumdis-2013-203863

• Cardiovascular disease in autoimmune rheumatic diseases

  Autoimmunity Reviews · 2013 · 10.1016/j.autrev.2013.03.013

• Pathogenesis of antiphospholipid syndrome: understanding the antibodies

  Nature Reviews Rheumatology · 2011 · 10.1038/nrrheum.2011.52

• ANA screening: an old test with new recommendations

  Annals of the Rheumatic Diseases · 2010 · 10.1136/ard.2009.127100

• Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

  Annals of the Rheumatic Diseases · 2008 · 10.1136/ard.2008.093179

• Anti-inflammatory and immunosuppressive drugs and reproduction.

  Arthritis Research & Therapy · 2006 · https://doi.org/10.1186/ar1957

• International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

  Journal of Thrombosis and Haemostasis · 2006 · 10.1111/j.1538-7836.2006.01753.x

• Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases

  Circulation · 2005 · https://doi.org/10.1161/circulationaha.104.507996

• Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor

  Blood · 2005 · 10.1182/blood-2005-03-1319

• Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus.

  PubMed · 2004

• Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

  Blood · 2003 · 10.1182/blood-2002-08-2349

• Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

  Arthritis & Rheumatism · 2002 · https://doi.org/10.1002/art.10187

• Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women

  Arthritis & Rheumatism · 2001 · 10.1002/1529-0131(200108)44:8<1832::aid-art320>3.0.co;2-c

• Statins prevent endothelial cell activation induced by antiphospholipid (anti-?2-glycoprotein I) antibodies: Effect on the proadhesive and proinflammatory phenotype

  Arthritis & Rheumatism · 2001 · 10.1002/1529-0131(200112)44:12<2870::aid-art475>3.0.co;2-y

• Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis

  Journal of Hepatology · 2001 · https://doi.org/10.1016/s0168-8278(00)00040-4

• Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2-glycoprotein I

  Arthritis & Rheumatism · 2000 · 10.1002/1529-0131(200001)43:1<140::aid-anr18>3.0.co;2-p

• Endothelial cells as target for antiphospholipid antibodies. Human Polyclonal and Monoclonal Anti‐β2‐Glycoprotein I Antibodies React In Vitro with Endothelial Cells Through Adherent β2‐Glycoprotein I and Induce Endothelial Activation

  Arthritis & Rheumatism · 1997 · 10.1002/art.1780400322

Current projects

No projects listed.